Cadrenal Therapeutics Stock (NASDAQ: CVKD) stock price, news, charts, stock research, profile.
Open | $0.480 |
Close | $0.460 |
Volume / Avg. | 114.674K / 251.795K |
Day Range | 0.459 - 0.504 |
52 Wk Range | 0.360 - 3.140 |
Market Cap | $7.298M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 40 |
Short Interest | 2.02% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cadrenal Therapeutics (NASDAQ: CVKD) through any online brokerage.
Other companies in Cadrenal Therapeutics’s space includes: Cingulate (NASDAQ:CING), Cocrystal Pharma (NASDAQ:COCP), Kiora Pharmaceuticals (NASDAQ:KPRX), Universe Pharmaceuticals (NASDAQ:UPC) and Palisade Bio (NASDAQ:PALI).
The latest price target for Cadrenal Therapeutics (NASDAQ: CVKD) was reported by HC Wainwright & Co. on Thursday, May 9, 2024. The analyst firm set a price target for 3.00 expecting CVKD to rise to within 12 months (a possible 558.04% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Cadrenal Therapeutics (NASDAQ: CVKD) is $0.4559 last updated May 10, 2024 at 5:52 PM EDT.
There are no upcoming dividends for Cadrenal Therapeutics.
Cadrenal Therapeutics’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Cadrenal Therapeutics.
Cadrenal Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.